# Chiari Malformation Type I: A Review of Pathophysiology, Cerebrospinal Fluid Flow Dynamics, Diagnosis, Surgical Management, and Its Relationship to Syringomyelia

**Authors:** Maryam S Alhosani, Sopio Gachechiladze

PMC · DOI: 10.7759/cureus.101226 · Cureus · 2026-01-10

## TL;DR

Chiari Malformation Type I is a neurological condition where part of the brain herniates, causing CSF flow issues and symptoms like headaches and coordination problems.

## Contribution

This review synthesizes current knowledge on CM-I pathophysiology, CSF dynamics, diagnosis, treatment, and its link to syringomyelia.

## Key findings

- CM-I causes CSF flow obstruction and brainstem compression, leading to various neurological symptoms.
- MRI and cine MRI are key diagnostic tools for evaluating CM-I and associated syringomyelia.
- Posterior fossa decompression is a common surgical treatment, with ongoing research into neuroprotective therapies.

## Abstract

Chiari malformation type I (CM-I) is a neurological disorder characterized by the herniation of the cerebellar tonsils through the foramen magnum, resulting in the obstruction of cerebrospinal fluid (CSF) flow and the compression of the brainstem and upper cervical spinal cord. These disturbances contribute to symptoms such as headaches exacerbated by Valsalva maneuvers, dizziness, neck pain, muscle weakness, sensory disturbances, and coordination difficulties. This review provides an overview of the pathophysiology of CM-I, the role of disrupted CSF dynamics, and diagnostic approaches including magnetic resonance imaging (MRI) and cine MRI. Moreover, this review provides current management strategies ranging from conservative therapy to posterior fossa decompression. Additionally, the relationship between CM-I and syringomyelia is examined, emphasizing how altered CSF flow contributes to syrinx formation. Greater understanding of these mechanisms supports earlier diagnosis and more targeted treatment, highlighting the need for continued research into neuroprotective therapies that enhance long-term outcomes and quality of life for patients with CM-I.

## Linked entities

- **Diseases:** Chiari malformation type I (MONDO:0007316), syringomyelia (MONDO:0017987)

## Full-text entities

- **Diseases:** neck pain (MESH:D019547), CM-I (MESH:D001139), Syringomyelia (MESH:D013595), coordination (MESH:D001259), dizziness (MESH:D004244), headaches (MESH:D006261), muscle weakness (MESH:D018908), neurological disorder (MESH:D009461), sensory disturbances (MESH:D012678)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12888059/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12888059/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12888059/full.md

---
Source: https://tomesphere.com/paper/PMC12888059